CORPORATE REORGANIZATION AND EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Narrative) (Details) - USD ($)		1 Months Ended		12 Months Ended
	Aug. 07, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 31, 2019	Nov. 30, 2018
Revenue stream		$ 1,852,000	$ 802,000	$ 33,256,000	$ 18,655,000
Atvio and CureCell [Member]
Debt contributed				2,300,000
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain				$ 4,500,000
CureCell [Member]
Equity Method Investment, Ownership Percentage				94.12%
Stock Issued During Period, Shares, Acquisitions				202,846
Other intangible assets				$ 3,933,000
Total consideration transferred				4,790,000
CureCell [Member] | Customer Relationships [Member]
Other intangible assets				$ 859,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				10 years
CureCell [Member] | Know-How [Member]
Other intangible assets				$ 3,074,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life				12 years
Atvio [Member]
Stock Issued During Period, Shares, Acquisitions				83,965
Total consideration transferred				$ 890,000
Masthercell Global [Member] | Stock Purchase Agreement [Member]
Value of all Atvio and CureCell equity interests transfer	$ 1